Cancer Therapeutics CRC is a successful cancer research organisation with a primary focus on small molecule drug discovery. We partner with Australia’s leading research institutes, universities and biotechnology companies to bridge the gap between basic research and commercial outcomes.
We are translating Australia’s cancer research into the next generation of gentler and more effective therapies for patients.
Cancer Therapeutics CRC has a track record of success and has executed preclinical licensing deals and research collaborations with international pharmaceutical companies, which have delivered millions of dollars in revenue to the Australian biomedical industry.
Cancer Therapeutics CRC is funded as part of the Commonwealth government’s Cooperative Research Centres (CRC) Program. This Program supports industry-led collaborations between industry, researchers and the community. It’s a proven model for linking researchers with industry to focus on research and development towards use and commercialisation.
Further information about the CRC Program is available at www.business.gov.au